The stroke prognosis instrument II (SPI-II): A clinical prediction instrument for patients with transient ischemia and nondisabling ischemic stroke

Walter N. Kernan, Catherine M. Viscoli, Lawrence M. Brass, Robert W. Makuch, Philip M. Sarrel, Robin S. Roberts, Michael Gent, Peter Rothwell, Ralph L. Sacco, Ruei Che Liu, Bernadette Boden-Albala, Ralph I. Horwitz

Research output: Contribution to journalArticle

Abstract

Background and Purpose - In 1991 we developed the Stroke Prognosis Instrument (SPI-I) to stratify patients with transient ischemic attack or ischemic stroke by prognosis for stroke or death in 2 years. In this article we validate and improve SPI-I (creating SPI-II). Methods - To validate SPI-I, we applied it to 4 test cohorts and calculated pooled outcome rates. To create SPI-II, we incorporated new predictive variables identified in 1 of the test cohorts and validated it in the other 3 cohorts. Results - For SPI- I, pooled rates (all 4 test cohorts) of stroke or death within 2 years in risk groups I, II, and III were 9%, 17%, and 24%, respectively (P<0.01, log- rank test). SPI-II was created by adding congestive heart failure and prior stroke to SPI-I. Each patient's risk group was determined by the total score for 7 factors: congestive heart failure (3 points); diabetes (3 points); prior stroke (3 points); age >70 years (2 points); stroke for the index event (not transient ischemic attack) (2 points); hypertension (1 point); and coronary artery disease (1 point). Risk groups I, II, and III comprised patients with 0 to 3, 4 to 7, and 8 to 15 points, respectively. For SPI-I, pooled rates (3 cohorts excluding the SPI-II development cohort) of stroke or death within 2 years in risk groups I, II, and III were 9%, 17%, and 23%, respectively. For SPI-II, pooled rates were 10%, 19%, and 31%, respectively. In receiver operator characteristic analysis, the area under the curve was 0.59 (95% CI, 0.57 to 0.60) for SPI-I and 0.63 (95% CI, 0.62 to 0.65) for SPI-II, confirming the better performance of the latter. Conclusions - Compared with SPI-I, SPI-II achieves greater discrimination in outcome rates among risk groups SPI-II is ready for use in research design and may have a role in patient counseling.

Original languageEnglish (US)
Pages (from-to)456-462
Number of pages7
JournalStroke
Volume31
Issue number2
StatePublished - Feb 2000

Fingerprint

Ischemia
Stroke
Transient Ischemic Attack
Area Under Curve
Counseling
Coronary Artery Disease
Research Design

Keywords

  • Cerebral infarction
  • Cerebral ischemia, transient
  • Cerebrovascular disorders
  • Prognosis
  • Randomized controlled trials

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Neuroscience(all)

Cite this

Kernan, W. N., Viscoli, C. M., Brass, L. M., Makuch, R. W., Sarrel, P. M., Roberts, R. S., ... Horwitz, R. I. (2000). The stroke prognosis instrument II (SPI-II): A clinical prediction instrument for patients with transient ischemia and nondisabling ischemic stroke. Stroke, 31(2), 456-462.

The stroke prognosis instrument II (SPI-II) : A clinical prediction instrument for patients with transient ischemia and nondisabling ischemic stroke. / Kernan, Walter N.; Viscoli, Catherine M.; Brass, Lawrence M.; Makuch, Robert W.; Sarrel, Philip M.; Roberts, Robin S.; Gent, Michael; Rothwell, Peter; Sacco, Ralph L.; Liu, Ruei Che; Boden-Albala, Bernadette; Horwitz, Ralph I.

In: Stroke, Vol. 31, No. 2, 02.2000, p. 456-462.

Research output: Contribution to journalArticle

Kernan, WN, Viscoli, CM, Brass, LM, Makuch, RW, Sarrel, PM, Roberts, RS, Gent, M, Rothwell, P, Sacco, RL, Liu, RC, Boden-Albala, B & Horwitz, RI 2000, 'The stroke prognosis instrument II (SPI-II): A clinical prediction instrument for patients with transient ischemia and nondisabling ischemic stroke', Stroke, vol. 31, no. 2, pp. 456-462.
Kernan, Walter N. ; Viscoli, Catherine M. ; Brass, Lawrence M. ; Makuch, Robert W. ; Sarrel, Philip M. ; Roberts, Robin S. ; Gent, Michael ; Rothwell, Peter ; Sacco, Ralph L. ; Liu, Ruei Che ; Boden-Albala, Bernadette ; Horwitz, Ralph I. / The stroke prognosis instrument II (SPI-II) : A clinical prediction instrument for patients with transient ischemia and nondisabling ischemic stroke. In: Stroke. 2000 ; Vol. 31, No. 2. pp. 456-462.
@article{4db35500060c4ead84795b8f6af62e1d,
title = "The stroke prognosis instrument II (SPI-II): A clinical prediction instrument for patients with transient ischemia and nondisabling ischemic stroke",
abstract = "Background and Purpose - In 1991 we developed the Stroke Prognosis Instrument (SPI-I) to stratify patients with transient ischemic attack or ischemic stroke by prognosis for stroke or death in 2 years. In this article we validate and improve SPI-I (creating SPI-II). Methods - To validate SPI-I, we applied it to 4 test cohorts and calculated pooled outcome rates. To create SPI-II, we incorporated new predictive variables identified in 1 of the test cohorts and validated it in the other 3 cohorts. Results - For SPI- I, pooled rates (all 4 test cohorts) of stroke or death within 2 years in risk groups I, II, and III were 9{\%}, 17{\%}, and 24{\%}, respectively (P<0.01, log- rank test). SPI-II was created by adding congestive heart failure and prior stroke to SPI-I. Each patient's risk group was determined by the total score for 7 factors: congestive heart failure (3 points); diabetes (3 points); prior stroke (3 points); age >70 years (2 points); stroke for the index event (not transient ischemic attack) (2 points); hypertension (1 point); and coronary artery disease (1 point). Risk groups I, II, and III comprised patients with 0 to 3, 4 to 7, and 8 to 15 points, respectively. For SPI-I, pooled rates (3 cohorts excluding the SPI-II development cohort) of stroke or death within 2 years in risk groups I, II, and III were 9{\%}, 17{\%}, and 23{\%}, respectively. For SPI-II, pooled rates were 10{\%}, 19{\%}, and 31{\%}, respectively. In receiver operator characteristic analysis, the area under the curve was 0.59 (95{\%} CI, 0.57 to 0.60) for SPI-I and 0.63 (95{\%} CI, 0.62 to 0.65) for SPI-II, confirming the better performance of the latter. Conclusions - Compared with SPI-I, SPI-II achieves greater discrimination in outcome rates among risk groups SPI-II is ready for use in research design and may have a role in patient counseling.",
keywords = "Cerebral infarction, Cerebral ischemia, transient, Cerebrovascular disorders, Prognosis, Randomized controlled trials",
author = "Kernan, {Walter N.} and Viscoli, {Catherine M.} and Brass, {Lawrence M.} and Makuch, {Robert W.} and Sarrel, {Philip M.} and Roberts, {Robin S.} and Michael Gent and Peter Rothwell and Sacco, {Ralph L.} and Liu, {Ruei Che} and Bernadette Boden-Albala and Horwitz, {Ralph I.}",
year = "2000",
month = "2",
language = "English (US)",
volume = "31",
pages = "456--462",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - The stroke prognosis instrument II (SPI-II)

T2 - A clinical prediction instrument for patients with transient ischemia and nondisabling ischemic stroke

AU - Kernan, Walter N.

AU - Viscoli, Catherine M.

AU - Brass, Lawrence M.

AU - Makuch, Robert W.

AU - Sarrel, Philip M.

AU - Roberts, Robin S.

AU - Gent, Michael

AU - Rothwell, Peter

AU - Sacco, Ralph L.

AU - Liu, Ruei Che

AU - Boden-Albala, Bernadette

AU - Horwitz, Ralph I.

PY - 2000/2

Y1 - 2000/2

N2 - Background and Purpose - In 1991 we developed the Stroke Prognosis Instrument (SPI-I) to stratify patients with transient ischemic attack or ischemic stroke by prognosis for stroke or death in 2 years. In this article we validate and improve SPI-I (creating SPI-II). Methods - To validate SPI-I, we applied it to 4 test cohorts and calculated pooled outcome rates. To create SPI-II, we incorporated new predictive variables identified in 1 of the test cohorts and validated it in the other 3 cohorts. Results - For SPI- I, pooled rates (all 4 test cohorts) of stroke or death within 2 years in risk groups I, II, and III were 9%, 17%, and 24%, respectively (P<0.01, log- rank test). SPI-II was created by adding congestive heart failure and prior stroke to SPI-I. Each patient's risk group was determined by the total score for 7 factors: congestive heart failure (3 points); diabetes (3 points); prior stroke (3 points); age >70 years (2 points); stroke for the index event (not transient ischemic attack) (2 points); hypertension (1 point); and coronary artery disease (1 point). Risk groups I, II, and III comprised patients with 0 to 3, 4 to 7, and 8 to 15 points, respectively. For SPI-I, pooled rates (3 cohorts excluding the SPI-II development cohort) of stroke or death within 2 years in risk groups I, II, and III were 9%, 17%, and 23%, respectively. For SPI-II, pooled rates were 10%, 19%, and 31%, respectively. In receiver operator characteristic analysis, the area under the curve was 0.59 (95% CI, 0.57 to 0.60) for SPI-I and 0.63 (95% CI, 0.62 to 0.65) for SPI-II, confirming the better performance of the latter. Conclusions - Compared with SPI-I, SPI-II achieves greater discrimination in outcome rates among risk groups SPI-II is ready for use in research design and may have a role in patient counseling.

AB - Background and Purpose - In 1991 we developed the Stroke Prognosis Instrument (SPI-I) to stratify patients with transient ischemic attack or ischemic stroke by prognosis for stroke or death in 2 years. In this article we validate and improve SPI-I (creating SPI-II). Methods - To validate SPI-I, we applied it to 4 test cohorts and calculated pooled outcome rates. To create SPI-II, we incorporated new predictive variables identified in 1 of the test cohorts and validated it in the other 3 cohorts. Results - For SPI- I, pooled rates (all 4 test cohorts) of stroke or death within 2 years in risk groups I, II, and III were 9%, 17%, and 24%, respectively (P<0.01, log- rank test). SPI-II was created by adding congestive heart failure and prior stroke to SPI-I. Each patient's risk group was determined by the total score for 7 factors: congestive heart failure (3 points); diabetes (3 points); prior stroke (3 points); age >70 years (2 points); stroke for the index event (not transient ischemic attack) (2 points); hypertension (1 point); and coronary artery disease (1 point). Risk groups I, II, and III comprised patients with 0 to 3, 4 to 7, and 8 to 15 points, respectively. For SPI-I, pooled rates (3 cohorts excluding the SPI-II development cohort) of stroke or death within 2 years in risk groups I, II, and III were 9%, 17%, and 23%, respectively. For SPI-II, pooled rates were 10%, 19%, and 31%, respectively. In receiver operator characteristic analysis, the area under the curve was 0.59 (95% CI, 0.57 to 0.60) for SPI-I and 0.63 (95% CI, 0.62 to 0.65) for SPI-II, confirming the better performance of the latter. Conclusions - Compared with SPI-I, SPI-II achieves greater discrimination in outcome rates among risk groups SPI-II is ready for use in research design and may have a role in patient counseling.

KW - Cerebral infarction

KW - Cerebral ischemia, transient

KW - Cerebrovascular disorders

KW - Prognosis

KW - Randomized controlled trials

UR - http://www.scopus.com/inward/record.url?scp=0033950032&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033950032&partnerID=8YFLogxK

M3 - Article

VL - 31

SP - 456

EP - 462

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 2

ER -